Clinical TrialsSearch results
Number of results: 978
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- A Ph2, randomized, double-blind, dose finding study to describe the immunogenicity, safety and tolerability of VN-0200 in Japanese adults aged 60-80 years
- Prevention of respiratory syncytial viral infection
- Inoguchi Akihiro
- 2022-09-08
Completed
- A pharmacokinetic study of BBI-4000 gel in patients with primary focal hyperhidrosis in Japan
- Primary focal hyperhidrosis
- Yonemura Takuma
- 2021-07-09
Completed
- A pharmacokinetic study of NPC-15 Tablet (for adult use)
- Sleep-onset difficulty associated with mild cognitive impairment or dementia
- Eto Takashi
- 2023-03-02
Completed
- A Pharmacokinetic Trial of the OPB-111077 Current Formulation Versus the Modified Formulation by Single Administration in Healthy Adult Male Subjects
- Diffuse large B-cell lymphoma
- Sanada Nobuhito
- 2023-06-27
Completed
- A Phase 1 Clinical Trial of EB-1020 in Healthy Subjects (Single and Multiple Ascending Doses)
- Attention deficit hyperactivity disorder (ADHD)
- Sanada Nobuhito
- 2022-07-25
Completed
- A phase 1 mass balance study of [14C]TAS-205 in healthy volunteers
- Duchenne Muscular Dystrophy
- Nasermoaddeli Ali
- 2021-04-09
Completed
- A Phase 1 Mass Balance Study of Oral [14C] TAS-115 in Healthy Adult Male Subjects
- Chronic fibrosing interstitial lung diseases with a progressive phenotype
- Huang Jinhong
- 2021-09-07
Completed
- A phase 1 open-label study evaluating the effects of food on TAS-205 in healthy volunteers
- Duchenne Muscular Dystrophy
- Takeda Shin'ichi
- 2023-06-25
Completed
- A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Axatilimab When Administered by Intravenous Infusion to Healthy Japanese Participants
- GVHD, healthy voluteer
- Ono Shintaro
- 2023-02-27
Completed
- A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB054707 When Administered Orally to Healthy Japanese Participants
- Inflammatory disease
- On Shintaro
- 2021-10-18